Literature DB >> 29751381

The promise of using personalized genomic information to promote behavior change: is the debate over, or just beginning?

Kristi D Graves1, Jennifer L Hay2, Suzanne C O'Neill1.   

Abstract

Over recent years, significant debate has centered on whether and how communication of personalized genomic risk information can positively influence health behavior change. Several thoughtful commentaries have cautioned that efforts to incorporate genomic risk feedback to motivate health behavior change have had little success. As a field, we should consider the reasons for this limited success and be strategic in the next steps for this line of research. In this article, we consider several reasons that prior research that integrates personalized genomic information has had relative degrees of success in changing or maintaining health behaviors. We suggest ways forward and outline the possibilities presented by emerging technologies and novel approaches in translational genomic research.

Keywords:  behavior change; personalized genomic testing; personalized medicine

Year:  2014        PMID: 29751381     DOI: 10.2217/pme.13.110

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  3 in total

1.  Optimal Integration of Behavioral Medicine into Clinical Genetics and Genomics.

Authors:  William M P Klein; Colleen M McBride; Caitlin G Allen; Elva M Arredondo; Cinnamon S Bloss; Kimberly A Kaphingst; Amy C Sturm; Catharine Wang
Journal:  Am J Hum Genet       Date:  2019-02-07       Impact factor: 11.025

Review 2.  Toward the implementation of genomic applications for smoking cessation and smoking-related diseases.

Authors:  Alex T Ramsey; Li-Shiun Chen; Sarah M Hartz; Nancy L Saccone; Sherri L Fisher; Enola K Proctor; Laura J Bierut
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

3.  Weight-related genomic information and provider communication approach: looking through the lens of patient race.

Authors:  Sarah E Boland; Richard L Street; Susan Persky
Journal:  Per Med       Date:  2019-09-25       Impact factor: 2.119

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.